Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pardes Biosciences Inc (PRDS)

Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pardes Biosciences Inc 2173 SALK AVENUE SUITE 250 CARLSBAD CA 92008 USA

www.pardesbio.com P: 415-649-8758

Description:

Pardes Biosciences Inc. is a clinical-stage biopharmaceutical company. It discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. The company's lead product candidate includes PBI-0451, is being developed as a direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections, the virus responsible for COVID-19. Pardes Biosciences Inc., formerly known as FS Development Corp. II, is based in SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 133,946
Enterprise Value, $K -63,394
Shares Outstanding, K 62,012
Annual Sales, $ 0 K
Annual Net Income, $ -96,630 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,780 K
EBIT, $ -82,880 K
EBITDA, $ -83,940 K
60-Month Beta 0.42
% of Insider Shareholders 40.80%
% of Institutional Shareholders 91.89%
Float, K 36,711
% Float 59.20%
Short Volume Ratio 0.15

Growth:

1-Year Return -41.62%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 08/04/23
Latest Earnings Date 08/21/23
Earnings Per Share ttm -1.29
EPS Growth vs. Prev Qtr 40.00%
EPS Growth vs. Prev Year 62.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PRDS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -43.36%
Return-on-Assets % -40.71%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.86
Book Value/Share 2.51
Interest Coverage -31.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar